对C反应蛋白与MEESSI急性心力衰竭风险评分的增量值
Desiree Wussler1,2, Maria Belkin1,2, Samyut Shrestha1,2
1Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.
European journal of heart failure
|June 26, 2024
概括
将C反应蛋白 (CRP) 添加到MEESSI评分中可以改善急性心力衰竭 (AHF) 风险分层. 这种改进的模型可以更好地预测30天死亡率,并识别出更多低风险患者.
科学领域:
- 心脏病学 心脏病学
- 临床风险分层的临床风险分层
- 炎症生物标志物 炎症生物标志物
背景情况:
- 急性心力衰竭 (AHF) 具有显著的死亡风险.
- 目前的风险分层模型,如MEESSI-AHF得分,对于患者管理至关重要.
- 系统性炎症在AHF预后中的作用需要进一步调查.
研究的目的:
- 通过纳入C反应蛋白 (CRP) 水平来提高MEESSI-AHF风险评分.
- 评估CRP在预测AHF患者30天死亡率方面的增量值.
- 评估CRP添加对风险分层准确性和临床有用性的影响.
主要方法:
- 预期的多中心诊断研究 (BASEL V) 以AHF病例的中央裁决为中心.
- 使用12个独立的风险因素计算建立的MEESSI-AHF风险评分.
- 通过添加CRP来评估30天死亡率,在独立队列中验证后扩展后勤回归模型.
主要成果:
- 与原始模型 (c-statistic 0.79) 相比,包含CRP的扩展MEESSI模型显示出明显更高的预后准确性 (c-statistic 0.83).
- 改进的模型将更多的患者分层到最低风险组 (33.1%对20.3%).
- 证明了优良和改进的校准,结果在独立验证队列中得到证实.
结论:
- 通过CRP度量化系统性炎症为MEESSI模型的AHF风险分层提供了增量价值.
- 添加CRP可以提高AHF患者风险评估的准确性和临床实用性.
- 这些发现支持将炎症标志物整合到现有的AHF风险预测工具中.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
76
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
76
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
136
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
136
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419